Bortezomib Active Not Recruiting Phase 2 Trials for Chronic Graft Versus Host Disease Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01158105Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)